Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Clinical trial NCT05702853 · RECRUITING

Trial details

NCT number: NCT05702853
Sponsor: Medical University of South Carolina
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia

Start date: 2023-11-06
Primary completion: 2026-11-06
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.